Lack of Effect of Methimazole on Thyrocyte Cell-Surface Antigen Expression

References

• Weetman A P, McGregor A M, Hall R. Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol 1984; 21: 163–172
   PubMed Web of Science ®Google Scholar
• Ratanachaiyavong S, McGregor AM. Immunosuppressive effects of antithyroid drugs. Clin Endocrinol Metabol 1985; 14: 449–466
   PubMedGoogle Scholar
• Volpé R, Karlsson A, Jansson R., Dahlberg P. A. Evidence that antithyroid drugs induce remission in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol 1986; 25: 243–462
   Google Scholar
• Volpé R, Karlsson A, Jansson R, Dahlberg PA. Thyrostatic drugs act through modulation of thyroid cell activity to induce remission in Graves' disease. Acta Endocrinol (Copenhagen) 1987; 115: 305–311, (Supplement 281)
   Google Scholar
• Pinchera A, Liberti G, Martino E, Fenzi G F, Grasso L, Rovis L, Baschieri L. Effects of antithyroid therapy on the long acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metabol 1969; 29: 231–238
   PubMed Web of Science ®Google Scholar
• McGregor A M, Petersen M M, McLachlan S M, Rooke P, Rees-Smith B, Hall R. Carbimazole and the autoimmune response in Graves' disease. New Engl J Med 1980; 303: 302–307
   PubMed Web of Science ®Google Scholar
• Totterman T, Karlsson A, Bengtsson M, Mendel-Harvig I. Induction of circulating activated suppresor-like T cells by methimazole therapy for Graves' disease. New Engl J Med 1987; 316: 15–22
   PubMed Web of Science ®Google Scholar
• Volpé R. Immunoregulation in autoimmune thyroid disease (Editorial). New England. J Med 1987; 316: 44–46
   Google Scholar
• Fenzi G, Hashizume K, Roudebush C P, DeGroot LJ. Changes in thyroid stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab 1979; 48: 572–576
   PubMedGoogle Scholar
• Teng C S, Yeung R TT. Changes in thyroid stimulating activity in Graves' disease treated with antithyroid drugs, and its relationship to relapse. A prospective study. J Clin Endocrinol Metabol 1980; 50: 144–147
   PubMed Web of Science ®Google Scholar
• Ludgate M E, McGregor A M, Weetman A P, Ratanachaiyavong S, Lazarus L H, Hall R, Middleton GW. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Brit Med J 1984; 228: 526–530
   Google Scholar
• Madec A M, Allanic H, Genetet N, Guegeun M, Genetet C, Fauchet R, Stefanuth A, Orgiazzi J. T lymphocytes subsets at various stages of hyperthyroid Graves' disease; effect of carbimazole treatment and relationship with thyroid stimulating antibody levels and HLA status. J Clin Endocrinol Metabol 1986; 62: 117–121
   PubMedGoogle Scholar
• Weetman A P, McGregor A M, Hall R. Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immun Immunopath 1983; 28: 39–45
   PubMedGoogle Scholar
• Weetman A P, Holt M E, Campbell A K, Hall R, McGregor AM. Methimazole inhibits oxygen radical generation by monocytes: a potential role of immunosuppression. Brit Med J 1984; 288: 518–520
   PubMed Web of Science ®Google Scholar
• Gerstein H, Rastogi B, Iwatani Y, Iitaka M, Row V V, Volpé R. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism. Clin Invest Med 1987; 10: 337–344
   PubMed Web of Science ®Google Scholar
• Carel J C, Remy J J, Salermo J, Charriere J. Modulation of Class II antigen expression on human thyroid epithelial cells by antithyroid drugs. Proceedings of the 6th International Congress of Immunology, Toronto, Ontario, July 6–11, 1986, Abstract 3.47.7, p. 424, National Research Council of Canada, NRCC 25710, ISBN 0–660–53282–4
   Google Scholar
• Aguayo J, Iitaka M, Row V V, Volpé R. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon gamma induced HLA-DR expression. J Clin Endocrinol Metab 1988; 66: 903–908
   PubMed Web of Science ®Google Scholar
• Wenzel B E, Arnholdt H, Grammerstorf S, Gutekunst R, Scriba PC. Modulation of Class II antigen expression in human thyroid epithelial cell cultures. Acta Endocrinol (Copenhagen) 1987; 115: 21–26, (Supplement 281)
   PubMedGoogle Scholar
• Cohen S B, Weetman AP. Antithyroid drugs ameliorate thymectomy-induced experimental autoimmune thyroiditis. Auto 1988; I: 51–58
   Google Scholar
• Greer MA. Antithyroid drugs in the treatment of thyrotoxicosis. Thyr Today 1980; 1: 1–5
   Google Scholar
• Cooper DS. Antithyroid drugs. New Engl J Med 1984; 311: 1352–1362
   Google Scholar
• Portmann L, Hamada N, Heinrich G, DeGroot LJ. Antithyroid peroxidase in patients with autoimmune thyroid disease: possible identity with antimicrosomal antibody. J Clin Endocrinol Metabol 1985; 61: 1001–1003
   PubMed Web of Science ®Google Scholar
• Czarnocka B, Ruf J, Fernend M, Carayon P, Lissitzky S. Purification of human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid disease. FEBS (Federation of European Biochemical Society (Lett.)) 1985; 190: 147–152
   PubMed Web of Science ®Google Scholar
• Chiovato L, Vitti P, Lombardi A, Kohn L, Pinchera A. Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotrophin. J Clin Endocrinol Metabol 1985; 61: 12–18
   PubMed Web of Science ®Google Scholar
• Pinchera A, Mariotti S, Chiovato L, Vitti P, Lopez G, Lombardi A, Anelli S, Bechi R, Carayon P. Cellular localization of the microsomal antigen and the thyroid peroxidase antigen. Acta Endocrinol (Copenhagen) 1987; 115: 57–62, Supplement 281
   PubMedGoogle Scholar
• Iwatani Y, Gerstein H C, Iitaka M, Row V V, Volpé R. Thyrocyte DR expression and interferon gamma production in autoimmune thyroid disease. J Clin Endocrinol Metabol 1986; 63: 695–708
   PubMed Web of Science ®Google Scholar
• Van Herle A J, Vassart G, Dumont JS. Control of thyroglobulin synthesis and secretion. New Engl J Med 1979; 301: 239–249
   PubMed Web of Science ®Google Scholar
• Van Herle A J, Uller R P, Matthews M L, Brown L. Radioimmunoassay for the measurement of thyroglobulin in human serum. J Clin Invest 1973; 52: 1370–1377
   Google Scholar
• Carel J C, Charriere J. HLA-DR expression in thyroid glands with Graves' disease is a consequence of the infiltration of the gland by syngeneic lymphocytes. Immune intervention: Anti-la antibodies in the treatment of disease, J. Brochier. Academic Press, New York 1986; 101–108
   Google Scholar
• Jansson R, Dahlberg P A, Johansson H, Lindstrom B. Intrathyroidal concentrations of methimazole in patients with Graves' disease. J Clin Endocrinol Metabol 1983; 57: 129–132
   PubMed Web of Science ®Google Scholar
• Chan J YC, Walfish PG. Activated Ia+ T lymphocytes and their subsets in autoimmune thyroid diseases; analysis by dual laser flow microfluorocytometry. J Clin Endocrinol Metabol 1986; 62: 403–409
   PubMed Web of Science ®Google Scholar
• Sundick R S, Herdegen D, Brown T R, Bagchi N. Thyroiditis induced by dietary iodine may be due to increased immunogenicity of highly iodinated thyroglobulin. The Thyroid and Autoimmunity, HA. Drexhage, WM Wiersinga. Excerpta Medica, Elsevier, Amsterdam 1986; 213–214
   Google Scholar
• Feldman A, Schwartz A E, Friedman E W, Davies TF. Inhibition of thyroglobulin secretion by anti-thyroid drugs — another mechanism for immunosuppression by thionamides. Frontiers in Thyroidology, E. Medeiros-Neto, Gaitan. Plenum Press, New York 1986; Vol. 2: 1535–1538
   Google Scholar
• Ohtakara S, Izumi M, Hirayu H, Hagayama Y, Ishikawa N, Eguchi K, Ito K, Morimoto I, Okamoto S, Nagataki S. Thyroglobulins associated and not associated with microsomal antigen and the thyroid cell surface. Proceedings of the 69th Meeting of the Endocrine Society, Indianapolis, June 10–12, 1987, 76, Abstract 222
   Google Scholar
• Iwatani Y, Iitaka M, Gerstein H C, Row V V, Volpé R. Separate induction of MHC and thyroid microsomal antigen expression on thyroid cell monolayers. Enhancement of lectin-induced microsomal antigen expression by interferon-gamma. J Clin Endocrinol Metabol 1987; 64: 1302–1308
   PubMedGoogle Scholar